loadpatents
Patent applications and USPTO patent grants for Richer; Jennifer.The latest application filed is for "treatment of breast cancer".
Patent | Date |
---|---|
Treatment of Breast Cancer App 20210069154 - Protter; Andrew A. ;   et al. | 2021-03-11 |
FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast cancer Grant 10,434,075 - Cox , et al. O | 2019-10-08 |
Treatment of Breast Cancer App 20190262315 - Protter; Andrew A. ;   et al. | 2019-08-29 |
Treatment of breast cancer Grant 10,111,861 - Protter , et al. October 30, 2 | 2018-10-30 |
Fkbp52-specific Androgen Receptor Inhibitor, Mjc13, For Use In Treating Breast Cancer App 20170360725 - Cox; Marc B. ;   et al. | 2017-12-21 |
Treatment of Breast Cancer App 20170087132 - Protter; Andrew A. ;   et al. | 2017-03-30 |
Treatment of breast cancer Grant 9,517,229 - Protter , et al. December 13, 2 | 2016-12-13 |
Treatment Of Breast Cancer App 20140296312 - Protter; Andrew A. ;   et al. | 2014-10-02 |
MiRNAs dysregulated in triple-negative breast cancer Grant 8,507,195 - Richer , et al. August 13, 2 | 2013-08-13 |
Mirnas Dysregulated In Triple-negative Breast Cancer App 20120214864 - Richer; Jennifer ;   et al. | 2012-08-23 |
Progesterone receptor-regulated gene expression and methods related thereto App 20040132086 - Horwitz, Kathryn B. ;   et al. | 2004-07-08 |
Progesterone receptor-regulated gene expression and methods related thereto Grant 6,750,015 - Horwitz , et al. June 15, 2 | 2004-06-15 |
Progesterone receptor-regulated gene expression and methods related thereto App 20030027208 - Horwitz, Kathryn B. ;   et al. | 2003-02-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.